CymitQuimica logo
EGFR

EGFR

Les inhibiteurs du récepteur du facteur de croissance épidermique (EGFR) sont des composés qui bloquent la signalisation de l'EGFR, un récepteur souvent surexprimé dans divers cancers et qui joue un rôle crucial dans l'angiogenèse. Les inhibiteurs de l'EGFR sont utilisés pour prévenir la croissance tumorale et les métastases en perturbant les voies qui favorisent la formation de vaisseaux sanguins dans les tumeurs. Ces inhibiteurs sont largement utilisés dans la recherche et le traitement du cancer. Chez CymitQuimica, nous offrons une sélection diversifiée d'inhibiteurs de l'EGFR de haute qualité pour soutenir vos recherches en oncologie et angiogenèse.

572 produits trouvés pour "EGFR"

Trier par

Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
produits par page.
  • JAK 3 inhibitor IV

    CAS :
    <p>JAK 3 inhibitor IV (ZM 39923 hydrochloride) is a JAK1/3 inhibitor with pIC50 of 4.4/7.1, almost no activity to JAK2 and modestly potent to EGFR; also found to</p>
    Formule :C16H19NO
    Degré de pureté :98%
    Couleur et forme :Solid
    Masse moléculaire :241.33
  • EGFR-IN-43


    <p>EGFR-IN-43 (17c) is a potent EGFR inhibitor with ER antagonist action, tamoxifen/endoxifen+gefitinib linkage, and strong anticancer activity.</p>
    Formule :C50H55ClFN5O5
    Couleur et forme :Solid
    Masse moléculaire :860.45
  • EGFR-IN-162


    <p>EGFR-IN-162 (compound 20) is an effective EGFR inhibitor that enhances both early and late apoptosis (EGFR) as well as necrosis (necrosis). It shows potential for use in breast cancer research.</p>
    Formule :C27H31N3O2
    Couleur et forme :Solid
    Masse moléculaire :429.24163
  • EGFR/PI3Kα-IN-1


    <p>EGFR/PI3Kα-IN-1 (compound 30k), a dual EGFR/PI3Kα inhibitor, exhibits potent activity with IC 50 values of 3.6 nM (EGFRL858R/T790M) and 30 nM (PI3Kα). It effectively inhibits tumor cell proliferation and demonstrates significant anticancer activity.</p>
    Formule :C50H49N11O5S
    Couleur et forme :Solid
    Masse moléculaire :916.06
  • YH32367


    <p>YH32367 (ABL105) is a bispecific antibody targeting HER2 and 4-1BB. It induces the secretion of IFN-γ, resulting in the death of tumor cells when co-cultured with hPBMC and HER2-expressing tumor cells. YH32367 demonstrates notable antitumor activity.</p>
    Couleur et forme :Odour Liquid
  • DSPE-PEG2000-GE11


    <p>DSPE-PEG2000-GE11 is a PEG compound composed of DSPE and an EGFR-targeting peptide (GE11). GE11 is applicable for cancer cells that overexpress EGFR. DSPE-PEG2000-GE11 is utilized in drug delivery.</p>
    Couleur et forme :Odour Solid
  • EGFR-IN-140


    <p>EGFR-IN-140 (Compound 31) is an inhibitor of EGFR, effectively targeting both wild-type EGFR and the EGFRL858R/T790M/C797S mutant, with Ki values of 0.95 nM and 2.1 nM, respectively. Additionally, it inhibits EGFRdel19/T790M/C797S in Ba/F3 cells with an IC50 of 56.9 nM and demonstrates antitumor activity in mouse models.</p>
    Formule :C27H37FN8O2
    Couleur et forme :Solid
    Masse moléculaire :524.633
  • AG-1478 hydrochloride

    CAS :
    <p>AG1478 HCl is an epidermal growth factor receptor protein inhibitor.</p>
    Formule :C16H15Cl2N3O2
    Couleur et forme :Solid
    Masse moléculaire :352.21
  • IBI-334


    <p>IBI-334 is a bispecific antibody targeting both B7-H3 and EGFR. It features an EGFR arm responsible for signal blocking, connected to a modified B7-H3 arm that ensures optimal affinity and binding. The antibody is afucosylated to enhance its antibody-dependent cellular cytotoxicity (ADCC) effects. IBI-334 is widely applicable in EGFR-driven solid tumors.</p>
    Couleur et forme :Odour Liquid
  • MS9427

    CAS :
    <p>MS9427: PROTAC EGFR degrader, 7.1 nM (WT), 4.3 nM (L858R); targets mutant via UPS and autophagy; inhibits NSCLC cell growth; anticancer research.</p>
    Formule :C48H58ClFN8O12
    Couleur et forme :Solid
    Masse moléculaire :993.47
  • Lyso-Monosialoganglioside GM3

    CAS :
    <p>Lyso-Monosialoganglioside GM3 (Lyso-GM3) is an analog of Ganglioside GM3 with antitumor properties. It inhibits the increase in EGFR kinase activity induced by EGF in A431 epithelial cancer cells.</p>
    Formule :C41H74N2O20
    Couleur et forme :Solid
    Masse moléculaire :915.028
  • HER2-IN-14

    CAS :
    <p>HER2-IN-14 (Compound 34) is a potent inhibitor of HER2, achieving an inhibitory concentration (IC50) of 18 nM.</p>
    Formule :C26H23ClF2N8O3
    Couleur et forme :Solid
    Masse moléculaire :568.96
  • PRMT5/EGFR-IN-1


    PRMT5/EGFR-IN-1 (Compound 10p) is an orally active dual inhibitor targeting PRMT5 and EGFR, with IC50 values of 15.47 μM and 19.31 μM, respectively. It demonstrates antiproliferative activity against the A549, MCF7, HeLa, and MDA-MB-231 cell lines. This compound also exhibits favorable pharmacokinetic (PK) and pharmacodynamic (PD) properties in vivo and significantly inhibits the growth of MCF7 orthotopic xenograft tumors.
    Formule :C27H22F6N2O2
    Masse moléculaire :520.15855
  • PROTAC EGFR degrader 2


    <p>Potent PROTAC EGFR degrader 2; IC50: 4.0 nM, DC50: 36.51 nM; inhibits cell growth; for NTR-responsive synthesis.</p>
    Formule :C58H72ClFN12O8S
    Couleur et forme :Solid
    Masse moléculaire :1151.78
  • EGFR-IN-127


    <p>EGFR-IN-127 is an ATP-competitive inhibitor targeting EGFR, with IC50 values of 136.3 nM for EGFRdel19 and 161.2 nM for EGFRdel19/T790M/C797S. This compound holds potential for the study of non-small cell lung cancer (NSCLC).</p>
    Couleur et forme :Odour Solid
  • Timigutuzumab

    CAS :
    <p>Timigutuzumab (GEXMab73) is a humanized monoclonal antibody designed to target ErbB2, showing potential application in cancer research [1].</p>
    Couleur et forme :Liquid
  • EGFR-IN-124


    <p>EGFR-IN-124 (compound 10A) is an EGFR inhibitor with an IC50 value of 0.54 μM, utilized in cancer research.</p>
    Couleur et forme :Odour Solid
  • BMS-599626 2HCL(714971-09-2 Free base)

    CAS :
    <p>BMS-599626 2HCL (AC480 2HCl) is a BMS-599626 derivative.</p>
    Formule :C27H29Cl2FN8O3
    Degré de pureté :99.11%
    Couleur et forme :Odour Solid
    Masse moléculaire :603.47
  • Cetuximab (PBS)


    <p>Cetuximab (PBS) is a human IgG1 monoclonal antibody that inhibits the epidermal growth factor receptor (EGFR), with a dissociation constant (Kd) of 0.201 nM for EGFR as measured by the SPR method. It exhibits potent antitumor activity.</p>
    Couleur et forme :Odour Liquid
  • OK2


    <p>OK2, a specific inhibitor of the CCN2/EGFR interaction, effectively disrupts this interaction by binding to the CT domain of CCN2.</p>
    Formule :C42H62N14O9
    Degré de pureté :98%
    Couleur et forme :Solid
    Masse moléculaire :907.03